Vaccine

Population consultation, two-way communication and decision

An example of population consultation project was started recently by the French Ministry of Health, Marisol Touraine, who intends to consult the population on the matter of mandatory vaccination, as a part of a wide-ranging review of immunisation policies. This initiative comes after a report confirmed that vaccination is a sensitive society issue, which needs a large consultation of all stakeholders, including the civil society, with the aim of engaging them in a discussion about immunisation and its importance to public health. 

Country: 
France
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Citizens' Mobilization, Local Activities, Vaccination
Tags: 
Vaccine, risk communication, science-in-society

The health mediation in Bulgaria

The Bulgarian health mediator model was developed based on the experience of the Dutch Institute of Public Health and on the Romanian model of health mediators, which was presented by the Romani CRISS Foundation and the Romanian Ministry of Health.

Country: 
Bulgaria
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Human Rights, Local Activities, Vaccination
Tags: 
best practice, Vaccine, communication, Roma

Changing the citizen behaviour to improve public health and increase vaccination awareness – Carta Italiana

A very recent and innovative example of good practice concerning awareness campaigns is the “Italian Chart for the Promotion of Vaccinations”, a recent call for action whose website is: http://www.teamvaxitalia.it/. Namely, the Chart is the result of the efforts of the “TeamVaxItaly” movement that had been founded in a civil society meeting in Fano (Italy) in October 2015.

Country: 
Italy
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Human Rights, Local Activities, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, best practice

Too long time for a new vaccine in case of an emerging infectious threat

November 9, 2016

In 2009 A(H1N1) pandemic, vaccines were ready and could be supplied only when the peak of the pandemic was already decreasing in most European countries, discouraging people from getting vaccinated. Since the disease was not as severe as it was feared in the beginning, the consequences of this delay were not that serious, even if some lives could have been saved if the vaccines were available in advance. Ebola vaccine also arrived to West Africa when the epidemic was over, while a zika vaccine is still very far away. According to Thomas Breuer, however, GSK Chief Medical Officer, in case of another flu pandemic, a better cooperation among stakeholders and new technologies could accelerate the production and supply of new vaccines.

Target: 
Government and Public Health, Healthcare Professionals, Industry & Commerce
Topic: 
Stakeholders, Vaccination
Tags: 
Video, H1N1, pandemic, flu, influenza, swine flu, Ebola, zika, Vaccine

A first glance at ASSET citizen consultation

Saturday, October 29, 2016 - 10:23

Citizens across Europe participated to the daylong citizen consultations organized by the ASSET project at the end of September.

Target: 
Citizens, Decision Makers, Government and Public Health
Topic: 
Citizens' Mobilization, Local Activities, Stakeholders, Vaccination
Tags: 
citizen consultation, gender issues, Vaccine, science-in-society, communication

Should we vaccinate healthy children against flu?

October 24, 2016

While USA recommend universal flu vaccination for 6 months age, some European countries have different strategies, targeting only children with chronic diseases. Susanna Esposito, professor of Paediatrics at the University of Milan, Italy and president of WAIDID (World Association for Infectious Diseases) advocates for a wider coverage against influenza in healthy children as well.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Tags: 
Video, Vaccine, flu, influenza

Epidemic preparedness and response: Europe listens to the citizens’ voice

Friday, September 23, 2016 - 12:21

One day, eight countries, fifty participants for each of them, open discussions and a series of questions. These are the ingredients of the citizen consultations organized by ASSET on September 24th, to voice people’s opinion on epidemic preparedness and response.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, School and Education
Topic: 
Citizens' Mobilization, Local Activities, Mutual Learning, Policy, Prevention, Stakeholders, Vaccination
Tags: 
citizen consultation, Vaccine, Vaccine safety, science-in-society

MycoSynVac: synthetic biology, paying attention to ethical issues

Thursday, September 22, 2016 - 09:11

Vaccines have had broad medical impact, but existing vaccine technologies and production methods are limited in their ability to respond to certain pathogens. Other hurdles are due to difficulties in large scale production. MycoSynVac project proposes a new way for developing vaccines, by using of cutting-edge synthetic biology methodologies to engineer Mycoplasma pneumoniae as a universal chassis for vaccination.

Target: 
Industry & Commerce
Topic: 
Microbiology, Stakeholders, Vaccination
Tags: 
Vaccine, ethics, synthetic biology

Stopping H7N9 bird flu by vaccines

September 21, 2016

While the number of human cases of H7N9 bird flu is rising in China, and H5N1 is a persistent threat, different strategies of prevention are being considered. In a “one health” approach, vaccination of poultry is one of the possibilities, according to Ivan Hung, Clinical Associate Professor and Honorary Consultant in the Department of Medicine at the Queen Mary Hospital of the University of Hong Kong.

Topic: 
Vaccination
Tags: 
Video, H7N9, flu, influenza, Vaccine

TeamVax Italy and the Italian Charter for the promotion of immunization

Friday, September 16, 2016 - 10:32

Parents, healthcare workers, bloggers and science communicators have launched a positive experience in Italy, with the aim of sharing and promoting scientific information towards an important public health goal: to face the drop in vaccine coverage.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Citizens' Mobilization, Human Rights, Local Activities, Prevention, Social Media, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, engagement, science-in-society

Pages

Subscribe to Vaccine

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence